Everitt at al. aimed to determine the unadjusted 30-day readmission rate for CHD patients who underwent congenital heart surgery and identify demographic and clinical risk factors that predict unplanned 30-day readmission [4]. They analysed a retrospective cohort of 971 adult and paediatric patients with CHD who underwent congenital heart surgery from 2011-2012. The patient characteristics and outcomes are described in the Table below.
Table: Patient characteristics and outcomes. Adapted from Everitt et al. (2019)
Some clear differences emerged between readmitted and non-readmitted patients. Patients with a history of previous cardiac surgery, longer postoperative length of stay, and nutritional and haematologic comorbidities were more likely to experience unplanned 30-day readmission than patients who underwent single ventricle repair, pulmonary artery surgery, or a heart transplant. Also, patients aged 1-18 years or who underwent septal defect repair were less likely to be admitted.
In conclusion, unplanned hospital readmission is common after congenital cardiac surgery, the unadjusted 30-day readmission rate being 14.6%. Yet, it was pointed out that identification of hospital readmission depends on successful linkage of patients from the STS database into Emory University surveillance repository and accurate administrative documentation; thus posing a limitation of this trial.
- Cedars AM, et al. Am J Cardiol. 2016;117(11):1821-1825.
- Opotowsky AR, et al. J Am Coll Cardiol. 2009;54(5):460-467.
- Kim YY, et al. Congenit Heart Dis. 2017;12(2):159-165.
- Everitt I, et al. Abstract 1282-490. ACC 2019, 16-18 March, New Orleans, USA.
Posted on
Previous Article
« Substantial impact of temporary interruptions of warfarin versus DOAC Next Article
Patients with polyvascular disease significantly undertreated with lipid lowering therapies »
« Substantial impact of temporary interruptions of warfarin versus DOAC Next Article
Patients with polyvascular disease significantly undertreated with lipid lowering therapies »
Table of Contents: ACC 2019
Featured articles
Acute and Stable Ischaemic Heart Disease
Arrhythmias and Clinical Electrophysiology
Substantial impact of temporary interruptions of warfarin versus DOAC
Smartwatch can detect atrial fibrillation with high degree of accuracy
Congenital Heart Disease
Heart Failure and Cardiomyopathies
Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications
High 5-year survival rates for older HF patients without initial severe comorbidity
Pulmonary Arterial Hypertension and Venous Thromboembolism
Interventional Cardiology
Vascular Medicine
Lower rates stroke/SE with DOACs in frail non-valvular AF patients
Similar rates of stroke/SE associated with DOAC vs warfarin use in obese non-valvular AF patients: Results from an observational registry
Convincing evidence of the role of icosapent in reducing subsequent CV events
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com